Published in
Elsevier, European Journal of Cancer, (95), p. 93-101
DOI: 10.1016/j.ejca.2018.03.013
Links
Tools
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients
Journal article published in 2018 by
E. Jacquet,
A. Lardy-Cléaud,
B. Pistilli,
S. Franck,
P. Cottu 
,
S. Delaloge,
M. Debled,
L. Vanlemmens,
M. Leheurteur,
A. V. Guizard,
L. Laborde,
L. Uwer,
W. Jacot,
D. Berchery,
I. Desmoulins
and other authors.
,
S. Delaloge,
M. Debled,
L. Vanlemmens,
M. Leheurteur,
A. V. Guizard,
L. Laborde,
L. Uwer,
W. Jacot,
D. Berchery,
I. Desmoulins
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 